MEP20108A - Spherical telithromycin clusters, method for the production and use thereof in the preparation of pharmaceutical forms - Google Patents

Spherical telithromycin clusters, method for the production and use thereof in the preparation of pharmaceutical forms

Info

Publication number
MEP20108A
MEP20108A MEP-201/08A MEP20108A MEP20108A ME P20108 A MEP20108 A ME P20108A ME P20108 A MEP20108 A ME P20108A ME P20108 A MEP20108 A ME P20108A
Authority
ME
Montenegro
Prior art keywords
preparation
production
pharmaceutical forms
telithromycin
spherical
Prior art date
Application number
MEP-201/08A
Other languages
Bosnian (bs)
English (en)
Inventor
Jean-Yves Godard
Valerie Rognon
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9549351&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MEP20108(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of MEP20108A publication Critical patent/MEP20108A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
MEP-201/08A 1999-08-26 2000-08-28 Spherical telithromycin clusters, method for the production and use thereof in the preparation of pharmaceutical forms MEP20108A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9910810A FR2797875B1 (fr) 1999-08-26 1999-08-26 Agglomerats spheriques de telithromycine, leur procede de preparation et leur application dans la preparation de formes pharmaceutiques
PCT/FR2000/002393 WO2001014393A2 (fr) 1999-08-26 2000-08-28 Agglomerats spheriques de telithromycine, leur procede de preparation et leur application dans la preparation de formes pharmaceutiques

Publications (1)

Publication Number Publication Date
MEP20108A true MEP20108A (en) 2010-06-10

Family

ID=9549351

Family Applications (2)

Application Number Title Priority Date Filing Date
MEP-201/08A MEP20108A (en) 1999-08-26 2000-08-28 Spherical telithromycin clusters, method for the production and use thereof in the preparation of pharmaceutical forms
MEP-2008-201A ME00112B (me) 1999-08-26 2000-08-28 Sferni aglomerati telitromicina,postupak za njihovo dobijanje i njihova primena u dobijanju farmaceutskih oblika

Family Applications After (1)

Application Number Title Priority Date Filing Date
MEP-2008-201A ME00112B (me) 1999-08-26 2000-08-28 Sferni aglomerati telitromicina,postupak za njihovo dobijanje i njihova primena u dobijanju farmaceutskih oblika

Country Status (34)

Country Link
US (1) US6825218B1 (xx)
EP (1) EP1212336B1 (xx)
JP (1) JP4871467B2 (xx)
KR (1) KR100718222B1 (xx)
CN (1) CN1183151C (xx)
AR (1) AR025398A1 (xx)
AT (1) ATE255590T1 (xx)
AU (1) AU774385B2 (xx)
BR (1) BR0013569B1 (xx)
CA (1) CA2382497C (xx)
CO (1) CO5190666A1 (xx)
CZ (1) CZ2002594A3 (xx)
DE (1) DE60006976T2 (xx)
DK (1) DK1212336T3 (xx)
EA (1) EA005080B1 (xx)
ES (1) ES2209970T3 (xx)
FR (1) FR2797875B1 (xx)
HK (1) HK1049167B (xx)
HR (1) HRP20020167B1 (xx)
HU (1) HU229075B1 (xx)
IL (2) IL148128A0 (xx)
ME (2) MEP20108A (xx)
MX (1) MXPA02001988A (xx)
NO (1) NO322622B1 (xx)
PL (1) PL204100B1 (xx)
PT (1) PT1212336E (xx)
RS (1) RS50433B (xx)
SI (1) SI1212336T1 (xx)
SK (1) SK287588B6 (xx)
TR (1) TR200200506T2 (xx)
TW (1) TWI272949B (xx)
UA (1) UA73523C2 (xx)
WO (1) WO2001014393A2 (xx)
ZA (1) ZA200201599B (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9902202D0 (sv) * 1999-06-10 1999-06-10 Astra Ab Production of aggregates
FR2821747B1 (fr) * 2001-03-09 2004-07-02 Ethypharm Lab Prod Ethiques Suspension de telithromycine a gout masque
US20040013737A1 (en) * 2002-07-19 2004-01-22 Philippe Becourt Taste masked oral composition of telithromycin
WO2004009059A1 (en) * 2002-07-19 2004-01-29 Aventis Pharma S.A. Taste masked oral composition of telithromycin
EP1524966B1 (en) * 2002-07-19 2009-11-25 Aventis Pharma S.A. Taste masked oral composition of telithromycin
DK1610878T3 (da) * 2003-02-21 2014-12-01 Univ Bath Fremgangsmåde til fremstilling af partikler
WO2005007143A2 (en) * 2003-07-14 2005-01-27 The Board Of Trustees Of The University Of Illinois Use of makrolides and ketolides for the treatment of tuberculosis
WO2007039914A2 (en) * 2005-10-06 2007-04-12 Alembic Limited Novel polymorphs of telithromycin
US20090075917A1 (en) * 2007-09-19 2009-03-19 Protia, Llc Deuterium-enriched telithromycin
KR101324862B1 (ko) * 2011-07-12 2013-11-01 (주)에이에스텍 클로피도그렐 황산수소염의 구형 입자, 이를 포함하는 약학적 조성물 및 이의 제조방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0130160B1 (en) * 1983-06-22 1988-01-07 The Ohio State University Research Foundation Small particle formation
JPH02227130A (ja) * 1989-02-28 1990-09-10 Taisho Pharmaceut Co Ltd 球形微小凍結粒子の製造法
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.

Also Published As

Publication number Publication date
ES2209970T3 (es) 2004-07-01
EP1212336B1 (fr) 2003-12-03
BR0013569A (pt) 2002-05-14
FR2797875B1 (fr) 2001-10-19
TWI272949B (en) 2007-02-11
PL353137A1 (en) 2003-10-20
TR200200506T2 (tr) 2002-08-21
HK1049167B (zh) 2005-08-19
NO322622B1 (no) 2006-11-06
ZA200201599B (en) 2003-04-30
AU7018100A (en) 2001-03-19
HUP0202842A3 (en) 2003-03-28
UA73523C2 (uk) 2005-08-15
HU229075B1 (hu) 2013-07-29
JP4871467B2 (ja) 2012-02-08
WO2001014393A3 (fr) 2001-06-21
NO20020926D0 (no) 2002-02-26
PL204100B1 (pl) 2009-12-31
AR025398A1 (es) 2002-11-27
CA2382497A1 (fr) 2001-03-01
AU774385B2 (en) 2004-06-24
CN1183151C (zh) 2005-01-05
HK1049167A1 (en) 2003-05-02
CZ2002594A3 (cs) 2002-09-11
MXPA02001988A (es) 2002-08-20
US6825218B1 (en) 2004-11-30
EP1212336A2 (fr) 2002-06-12
FR2797875A1 (fr) 2001-03-02
RS50433B (sr) 2009-12-31
IL148128A (en) 2006-10-31
KR100718222B1 (ko) 2007-05-15
YU13202A (sh) 2004-09-03
CN1371386A (zh) 2002-09-25
SI1212336T1 (en) 2004-04-30
BR0013569B1 (pt) 2014-02-25
PT1212336E (pt) 2004-04-30
HRP20020167B1 (en) 2006-06-30
KR20020033771A (ko) 2002-05-07
EA200200294A1 (ru) 2002-08-29
SK2532002A3 (en) 2002-09-10
HUP0202842A2 (hu) 2003-01-28
JP2003507484A (ja) 2003-02-25
HRP20020167A2 (en) 2003-06-30
DK1212336T3 (da) 2004-03-15
ME00112B (me) 2010-10-10
NO20020926L (no) 2002-02-26
IL148128A0 (en) 2002-09-12
WO2001014393A2 (fr) 2001-03-01
CO5190666A1 (es) 2002-08-29
DE60006976D1 (de) 2004-01-15
EA005080B1 (ru) 2004-10-28
SK287588B6 (sk) 2011-03-04
CA2382497C (fr) 2011-06-28
ATE255590T1 (de) 2003-12-15
DE60006976T2 (de) 2004-10-21

Similar Documents

Publication Publication Date Title
MEP20108A (en) Spherical telithromycin clusters, method for the production and use thereof in the preparation of pharmaceutical forms
ES488888A1 (es) Procedimiento de fabricacion de una suspension acuosa de alumina
FI890195A (fi) Foliinihapon tai sen suolojen valmistusmenetelmä
DK0991653T3 (da) Nye forbindelser
ES554586A0 (es) Procedimiento para la obtencion de un producto activo de blanqueo a base de acidos alifaticos peroxicarboxilicos
FR2811318B1 (fr) Nouvelle forme cristalline gamma du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
HUP0302874A2 (hu) Eljárás risperidon előállítására
EE200100161A (et) Segamisest sõltumatud toimeainet aeglustatult vabastavad mitmeosalised ravimvormid ja nende valmistamismeetodid
ZA888396B (en) Process for the production of biodegradable microcapsules of water-soluble peptides and proteins,and microcapsules obtained by this process
HUP0402391A3 (en) Crystalline sodium salt of telmisartan, process for its production and pharmaceutical compositions containing it
MXPA02011389A (es) Forma de administracion farmaceutica para peptidos, procedimiento para su preparacion y aplicacion.
HUP9901616A3 (en) Novel benzofuranone derivatives, process for their production and pharmaceutical compositions of the same
NO20005838D0 (no) Farmasöytisk multipartikkelform med programmert og styrt frigivning, samt fremstilling derav
NO178252C (no) Fremgangsmåte for fremstilling av nye, faste, oralt administrerbare ifosfamidpreparater
HUT45486A (en) Process for producing pharmaceutics comprising substituted amino-propionic acid amides as active ingredient as well as the active ingredients
CA2000155A1 (en) Production of pigment compositions
HUP0204586A3 (en) Method for the production of protein preparations with essentially constant properties with regard to solubility and functionality within a ph range from about ph 3 to ph 10
AU2003300018A8 (en) Process for the preparation of tri-nitrogen containing heteroaryl-diamine derivatives useful as pharmaceutical agents and methods of producing pharmaceutical agents
NO20021269D0 (no) Fremgangsmåte for fremstilling av metylenbisfosfonsyrer og salter
IT1165465B (it) Forma microcristallina dell'isoxicam procedimento per ottenerla e composizioni farmaceutiche che la contengono
HUP0100751A3 (en) New aryl or heteroaryl quinolinylphosphonic acid derivatives, process for their preparation and pharmaceutical compositions containing them
IT1284030B1 (it) Metodo per la produzione di sospensioni acquose stabili, utili nelle composizioni farmaceutiche
ITVA20030017A1 (it) Carbossimetilcellulosa ad alta velocita' di dissoluzione in acqua.
NO994261D0 (no) FremgangsmÕte for fremstilling av trovafloxacinsyresalter
ZA989775B (en) Processes for producing 7-isoindoline-quinolone-carboxzlic acid derivative and its intermediate as well as salt of 7-isoindoline- quinolonecarboxylic acid derivative its hydrate and composition comprising the same as active ingredient